Gina Mazzariello is CLO at Amylyx Pharmaceuticals, Inc. (AMLX). They have made 13 open-market trades across 1 company since 2023, most recently 2026-09-10.
CIK 0001913765
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMLX | 190,838 | $5.6M |
Shares reported on the most recent Form 4, priced at the 2026-09-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMLX | SELL | 2026-09-10 | 2026-09-14 | $32.46 | $310K | -8.7% | -18.2% | — |
| AMLX | SELL · 10b5-1 | 2026-07-09 | 2026-07-13 | $17.96 | $539K | +1.9% | +34.9% | +59.0% |
| AMLX | SELL | 2026-03-02 | 2026-03-04 | $14.52 | $99K | -3.3% | +6.3% | -10.7% |
| AMLX | SELL | 2026-02-23 | 2026-02-25 | $14.14 | $48K | -1.6% | -6.7% | -5.9% |
| AMLX | SELL | 2026-02-02 | 2026-02-04 | $14.65 | $51K | +2.7% | +0.7% | +19.4% |
| AMLX | SELL | 2025-09-30 | 2025-10-02 | $14.58 | $257K | +4.6% | +0.3% | -10.9% |
| AMLX | SELL · 10b5-1 | 2025-08-12 | 2025-08-14 | $8.21 | $246K | +8.7% | +40.6% | +46.3% |
| AMLX | SELL | 2025-03-31 | 2025-04-02 | $3.48 | $32K | +10.5% | +50.7% | +81.6% |
| AMLX | SELL | 2025-03-03 | 2025-03-05 | $3.12 | $5K | +15.7% | +5.9% | +58.0% |
| AMLX | SELL | 2025-02-24 | 2025-02-26 | $3.15 | $13K | +9.1% | +14.4% | +47.5% |
| AMLX | SELL | 2025-02-03 | 2025-02-05 | $3.49 | $13K | -3.8% | +4.6% | +25.7% |
| AMLX | SELL | 2024-09-30 | 2024-10-02 | $3.20 | $28K | +18.9% | +87.4% | +25.6% |
| AMLX | SELL · 10b5-1 | 2024-05-15 | 2024-05-16 | $1.88 | $20K | -9.2% | -10.3% | +15.8% |
| AMLX | SELL | 2024-03-05 | 2024-03-07 | $18.73 | $29K | -2.0% | -10.0% | -41.1% |
| AMLX | SELL | 2024-02-23 | 2024-02-27 | $18.76 | $106K | -82.1% | -84.9% | -90.9% |
| AMLX | SELL · 10b5-1 | 2023-08-15 | 2023-08-17 | $20.88 | $257K | +8.7% | -6.3% | -34.5% |
| AMLX | SELL | 2023-02-24 | 2023-02-28 | $34.49 | $247K | -12.4% | -20.9% | -31.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.